Michael Frederick Klein, who serves as Executive Vice President and President of Personal Insurance at The Travelers Companies, Inc. (NYSE: TRV), completed the sale of 10,000 shares of the insurer's common stock on April 20, 2026, realizing proceeds of $3,037,690.
The disposition took place in two separate direct transactions. In the first block, Mr. Klein sold 6,730 shares at a weighted average price of $303.47 per share, with individual sale prices spanning from $303.10 to $303.87. In the second block, he sold 3,270 shares at a weighted average price of $304.3846 per share, with prices in that series ranging from $304.11 to $304.65.
Those sales followed an exercise earlier the same day in which Mr. Klein acquired 10,000 shares of Travelers common stock by exercising stock options. The exercise price on those options was $132.58 per share, meaning the acquisition cost amounted to $1,325,800. The options exercised were granted on February 4, 2023, and carry an expiration date of February 4, 2030.
After completing the exercise and the subsequent sales, Mr. Klein's reported holdings include 45,124.787 shares held directly, plus 1,888.708 shares held indirectly through a 401(k) plan.
At the time of the transactions, Travelers' share price was trading near the sale prices at $301.42, and the company carried a market capitalization of $64.06 billion. An InvestingPro assessment cited in relation to the company indicates that Travelers appears slightly undervalued on a Fair Value basis. Additional company metrics reported include a price-to-earnings ratio of 8.97 and a streak of 20 consecutive years of dividend increases, which the analysis notes as a sign of financial consistency.
Investors seeking deeper analysis can access the Pro Research Report referenced for Travelers and more than 1,400 other U.S. equities, which aggregates valuation and performance data for comparative review.
The insider transaction comes amid a flurry of analyst updates following Travelers' first-quarter 2025 results. The company reported core income of $7.71 per share for the quarter, exceeding the consensus estimate of $7.03 per share.
Several brokerages revised their price targets and views on Travelers after the earnings release. Roth/MKM raised its price target to $345 while maintaining a Buy rating. BMO Capital Markets increased its price target to $314, citing optimism about the trend in earnings-per-share revisions and stating an expectation that revisions will outpace consensus over the next one to two years.
Evercore ISI adjusted its price target to $321, pointing to in-line business insurance topline growth and an underwriting loss ratio that beat expectations, while noting weaker-than-expected personal lines growth. BofA Securities raised its price target to $276 despite Travelers missing both BofA's and consensus earnings estimates for the quarter, with net written premium growth falling short of expectations.
Meanwhile, BMO reaffirmed an Outperform rating, highlighting expectations of decelerating pricing in the commercial insurance market. Analysts' positive outlooks also reflect considerations such as the company's buyback potential, a factor specifically referenced in Evercore ISI's assessment of Travelers.
These developments - insider option exercise and sale activity, contemporaneous share price and valuation metrics, and a series of analyst target changes following quarterly results - present a collection of data points market participants can weigh when assessing Travelers' near-term prospects within the insurance sector.
For investors wishing to explore the company's valuation further, the Pro Research Report is available for this and other covered U.S. equities.